Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-000248
Filing Date
2024-03-20
Accepted
2024-03-20 17:07:28
Documents
93
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20231231x10k.htm   iXBRL 10-K 1983884
2 EX-31.1 tmb-20231231xex31d1.htm EX-31.1 16418
3 EX-32.1 tmb-20231231xex32d1.htm EX-32.1 8852
4 GRAPHIC tmb-20231231x10k001.jpg GRAPHIC 5726
5 GRAPHIC tmb-20231231x10k002.jpg GRAPHIC 5455
  Complete submission text file 0001410578-24-000248.txt   8821477

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20231231.xsd EX-101.SCH 75646
7 EX-101.CAL tmb-20231231_cal.xml EX-101.CAL 59093
8 EX-101.DEF tmb-20231231_def.xml EX-101.DEF 226025
9 EX-101.LAB tmb-20231231_lab.xml EX-101.LAB 488972
10 EX-101.PRE tmb-20231231_pre.xml EX-101.PRE 432357
97 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231231x10k_htm.xml XML 1480168
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9
Business Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9 905-541-3833
Target Group Inc. (Filer) CIK: 0001586554 (see all company filings)

EIN.: 463610035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55066 | Film No.: 24768511
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)